Had this come across my desk the other day.
--------------
FOR IMMEDIATE RELEASE
Contact Information:
Blair Ciecko
708-655-2045
blairc@celticchicago.com
Hivastan™ Receives Environmental Protection Agency Section 18 Approval
Schaumburg, IL, October 13, 2008 – Central Life Sciences, whose founders invented insect growth regulator technology more than 30 years ago, today announced that the Environmental Protection Agency (EPA) has renewed Section 18 clearance for Hivastan™. Hivastan™, a contact miticide with a thick, pliable formulation, is a powerful weapon to help beekeepers protect their bees against Varroa mites. It is currently available in seven states: Colorado, Idaho, Illinois, Mississippi, Missouri, Oregon and Washington.
“Varroa mites have plagued the beekeeping industry for decades, and unfortunately they have developed resistance to several of the previously approved control products,” explained Mark Taylor, Business Manager for Central Life Sciences. “The active ingredient in Hivastan™ is new to the beekeeping industry, which makes it a valuable tool in the battle against resistant Varroa mites.”
Hivastan™ contains fenpyroximate, a highly effective miticide that has been formulated into an easy-to-use delivery system. During testing with the U.S. Department of Agriculture, Hivastan™ was placed in hives for six weeks, providing effective Varroa control during and after treatment.
To provide maximum control, Central Life Sciences recommends treating all infested bee colonies with Hivastan™ once a year – prior to the first honey flow in the spring or in the fall after the last honey flow.
“Varroa mite control requires an integrated pest management approach,” said Taylor. “Given the resistance issues with currently registered products it is extremely important to follow a rotational strategy to slow down or prevent the development of resistance. Hivastan™ fits well into a rotational strategy for mite control.”
Hivastan™ is available in 25-pound buckets containing enough product to treat 50 hives. Each treatment consists of 8 oz (225 grams) of product per hive. This is enough to treat a typical colony for six weeks, and any excess product remaining after this period should be removed from the hive.
About Central Life Sciences
The Professional Agriculture Division, which markets Hivastan™ and Apistan®, is part of the Central Life Sciences strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, plants and companion animals around the world. As inventors of insect growth regulator technology more than 30 years ago, the founders of Central Life Sciences pioneered biorational pest control: using the insect’s chemistry as a means to reduce pest populations. For more information on Hivistan™, visit www.CentralApiary.com or call 1-800-248-7763.
###
Apistan is a registered trademark and Hivastan is a trademark of Wellmark International.
--------------
FOR IMMEDIATE RELEASE
Contact Information:
Blair Ciecko
708-655-2045
blairc@celticchicago.com
Hivastan™ Receives Environmental Protection Agency Section 18 Approval
Schaumburg, IL, October 13, 2008 – Central Life Sciences, whose founders invented insect growth regulator technology more than 30 years ago, today announced that the Environmental Protection Agency (EPA) has renewed Section 18 clearance for Hivastan™. Hivastan™, a contact miticide with a thick, pliable formulation, is a powerful weapon to help beekeepers protect their bees against Varroa mites. It is currently available in seven states: Colorado, Idaho, Illinois, Mississippi, Missouri, Oregon and Washington.
“Varroa mites have plagued the beekeeping industry for decades, and unfortunately they have developed resistance to several of the previously approved control products,” explained Mark Taylor, Business Manager for Central Life Sciences. “The active ingredient in Hivastan™ is new to the beekeeping industry, which makes it a valuable tool in the battle against resistant Varroa mites.”
Hivastan™ contains fenpyroximate, a highly effective miticide that has been formulated into an easy-to-use delivery system. During testing with the U.S. Department of Agriculture, Hivastan™ was placed in hives for six weeks, providing effective Varroa control during and after treatment.
To provide maximum control, Central Life Sciences recommends treating all infested bee colonies with Hivastan™ once a year – prior to the first honey flow in the spring or in the fall after the last honey flow.
“Varroa mite control requires an integrated pest management approach,” said Taylor. “Given the resistance issues with currently registered products it is extremely important to follow a rotational strategy to slow down or prevent the development of resistance. Hivastan™ fits well into a rotational strategy for mite control.”
Hivastan™ is available in 25-pound buckets containing enough product to treat 50 hives. Each treatment consists of 8 oz (225 grams) of product per hive. This is enough to treat a typical colony for six weeks, and any excess product remaining after this period should be removed from the hive.
About Central Life Sciences
The Professional Agriculture Division, which markets Hivastan™ and Apistan®, is part of the Central Life Sciences strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, plants and companion animals around the world. As inventors of insect growth regulator technology more than 30 years ago, the founders of Central Life Sciences pioneered biorational pest control: using the insect’s chemistry as a means to reduce pest populations. For more information on Hivistan™, visit www.CentralApiary.com or call 1-800-248-7763.
###
Apistan is a registered trademark and Hivastan is a trademark of Wellmark International.